Literature DB >> 7431175

Thrombocytopenia in the high-risk infant.

P Mehta, R Vasa, L Neumann, M Karpatkin.   

Abstract

One-hundred twenty-nine high-risk infants with thrombocytopenia and 238 control infants without thrombocytopenia were evaluated. Mothers of thrombocytopenic babies had similar history to those of nonthrombocytopenic babies, although fewer chronic narcotic abusers were found among mothers of thrombocytopenic babies. Thrombocytopenia was more common in babies less than 37 weeks' gestation and in sick babies compared to healthy babies. Sixty percent of infants had no recognizable cause of thrombocytopenia. Features associated with thrombocytopenia included umbilical line placement, respiratory assistance, hyperbilirubinemia, phototherapy, prematurity, respiratory distress syndrome, low Apgar score, sepsis, meconium aspiration, and necrotizing entercolitis. Thrombocytopenic babies had Apgar score, sepsis, meconium aspiration, and necrotizing entercolitis. Thrombocytopenic babies had more complications, more hemorrhage, and greater mortality than nonthrombocytopenic babies. Platelet size was increased in two babies with immune thrombocytopenia and in none of the others. This study shows that neonatal thrombocytopenia is often associated with high-risk factors and with increased hemorrhage, morbidity, and mortality. This relationship suggests an important prognostic value to platelet size was increased in two babies with immune thrombocytopenia and in none of the others. This study shows that neonatal thrombocytopenia is often associated with high-risk factors and with increased hemorrhage, morbidity, and mortality. This relationship suggests an important prognostic value to platelet counts, although the extent to which the thrombocytopenia contributed directly to morbidity and mortality is not clear.

Entities:  

Mesh:

Year:  1980        PMID: 7431175     DOI: 10.1016/s0022-3476(80)80272-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  19 in total

1.  Neonatal thrombocytopenia due to pregnancy induced hypertension.

Authors:  N Raizada; A Lal; R C Bhatia; B K Jain; K Chander; A Goyal
Journal:  Indian J Pediatr       Date:  1996 Mar-Apr       Impact factor: 1.967

Review 2.  Neonatal transfusion practice.

Authors:  N A Murray; I A G Roberts
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

3.  Differences between newborn and adult mice in their response to immune thrombocytopenia.

Authors:  Zhongbo Hu; William B Slayton; Lisa M Rimsza; Matthew Bailey; Hannes Sallmon; Martha C Sola-Visner
Journal:  Neonatology       Date:  2010-02-04       Impact factor: 4.035

Review 4.  Neonatal thrombocytopenia and megakaryocytopoiesis.

Authors:  Francisca Ferrer-Marin; Zhi-Jian Liu; Ravi Gutti; Martha Sola-Visner
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

5.  Significance of immature platelet fraction and CD41-positive cells at birth in early onset neonatal thrombocytopenia.

Authors:  Hirotaka Kihara; Norioki Ohno; Syuhei Karakawa; Yoko Mizoguchi; Rie Fukuhara; Michiko Hayashidani; Shinji Nomura; Kazuhiro Nakamura; Masao Kobayashi
Journal:  Int J Hematol       Date:  2010-03       Impact factor: 2.490

Review 6.  Neonatal thrombocytopenia: causes and management.

Authors:  I Roberts; N A Murray
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-09       Impact factor: 5.747

Review 7.  Platelet Transfusions in the Neonatal Intensive Care Unit.

Authors:  Katherine Sparger; Emoke Deschmann; Martha Sola-Visner
Journal:  Clin Perinatol       Date:  2015-05-27       Impact factor: 3.430

8.  Low antithrombin III in neonatal shock: DIC or non-specific protein depletion?

Authors:  B K Schmidt; T Muraji; A Zipursky
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

9.  Subcapsular hematoma of the liver in infants of very low birth weight.

Authors:  C A Ryan; N N Finer
Journal:  CMAJ       Date:  1987-06-15       Impact factor: 8.262

10.  Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan.

Authors:  Zhi-Jian Liu; Karin M Hoffmeister; Zhongbo Hu; Donald E Mager; Sihem Ait-Oudhia; Marlyse A Debrincat; Irina Pleines; Emma C Josefsson; Benjamin T Kile; Joseph Italiano; Haley Ramsey; Renata Grozovsky; Peter Veng-Pedersen; Chaitanya Chavda; Martha Sola-Visner
Journal:  Blood       Date:  2014-03-05       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.